Anthony Hunt, a director at $RGEN ($RGEN), sold 24,246 shares of the company on 11-21-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 14.8% of their shares. Following this trade, they now own 139,840 shares of $RGEN stock.

$RGEN Insider Trading Activity

$RGEN insiders have traded $RGEN stock on the open market 12 times in the past 6 months. Of those trades, 4 have been purchases and 8 have been sales.

Here's a breakdown of recent trading of $RGEN stock by insiders over the last 6 months:

• ANTHONY HUNT has traded it 6 times. They made 1 purchase, buying 2,000 shares and 5 sales, selling 46,437 shares.
• RALF KURIYEL (Senior VP, R&D) has traded it 3 times. They made 0 purchases and 3 sales, selling 11,613 shares.
• NICOLAS BARTHELEMY purchased 1,200 shares.
• MARTIN D MADAUS has traded it 2 times. They made 2 purchases, buying 1,615 shares and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RGEN Hedge Fund Activity

We have seen 225 institutional investors add shares of $RGEN stock to their portfolio, and 308 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ added 1,783,806 shares (+38.7%) to their portfolio in Q3 2024
• CHAMPLAIN INVESTMENT PARTNERS, LLC added 850,345 shares (+149.0%) to their portfolio in Q3 2024
• WELLINGTON MANAGEMENT GROUP LLP removed 784,065 shares (-100.0%) from their portfolio in Q3 2024
• FMR LLC removed 641,519 shares (-44.4%) from their portfolio in Q3 2024
• MILLENNIUM MANAGEMENT LLC removed 636,708 shares (-84.2%) from their portfolio in Q3 2024
• WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 634,990 shares (-100.0%) from their portfolio in Q2 2024
• CITADEL ADVISORS LLC added 512,438 shares (+14970.4%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.